| NCT ID | NCT03539133 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Heinrich-Heine University, Duesseldorf |
| Condition | ST-segment Elevation Myocardial Infarction (STEMI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2017-10-18 |
| Primary Completion | 2030-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2017-10-18 with a primary completion date of 2030-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality. Within the STEMI population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from STEMI patients. This cohort study is an open-end observational study to identify master switches in myocardial ischemia.
Eligibility Criteria
Inclusion Criteria: * Patients suffering from STEMI Exclusion Criteria: * \< 18 years
Contact & Investigator
Christian Jung, MD, PhD
PRINCIPAL INVESTIGATOR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Frequently Asked Questions
Who can join the NCT03539133 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ST-segment Elevation Myocardial Infarction (STEMI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03539133 currently recruiting?
Yes, NCT03539133 is actively recruiting participants. Contact the research team at christian.jung@med.uni-duesseldorf.de for enrollment information.
Where is the NCT03539133 trial being conducted?
This trial is being conducted at Düsseldorf, Germany.
Who is sponsoring the NCT03539133 clinical trial?
NCT03539133 is sponsored by Heinrich-Heine University, Duesseldorf. The principal investigator is Christian Jung, MD, PhD at Division of Cardiology, Pulmonary Disease and Vascular Medicine. The trial plans to enroll 1,000 participants.